What is the Incorporation or founding date of Ratnagene Lifescience Private Limited?

Ratnagene Lifescience Private Limited was incorporated on 15 Sep 2021.

What is authorized share capital and paid-up capital of Ratnagene Lifescience Private Limited?

The authorized share capital of Ratnagene Lifescience Private Limited is ₹ 90000000.0 and paid-up capital is ₹ 68600000.0.

Who are the current board members & directors of Ratnagene Lifescience Private Limited?

Currently 5 directors are associated with Ratnagene Lifescience Private Limited. Chetan Bipinchandra Shah, Deval Rajnikant Shah And 3 More.

What is the registered address of Ratnagene Lifescience Private Limited?

As per Ministry of Corporate Affairs (Mca), the registered address of Ratnagene Lifescience Private Limited is 1004-1006 10Th Floor North Tower Off. Ambli Road Opp. Ashok Vatika, India, Ahmadabad City, Gujarat, 380054.

What is the corporate identification number (CIN) and company number of Ratnagene Lifescience Private Limited?

The corporate identification number (CIN) of Ratnagene Lifescience Private Limited is U24231GJ2021PTC125613 and the company number is 125613 as per Ministry of Corporate Affairs (MCA).

What is the official website of Ratnagene Lifescience Private Limited?

The Official website of Ratnagene Lifescience Private Limited is https://www.ratnagene.com .

How many employees does Ratnagene Lifescience Private Limited currently have?

As Per 2023 financial reports, 45 employees are currently employed by Ratnagene Lifescience Private Limited.

What change has been observed in the net worth of Ratnagene Lifescience Private Limited, and by what percentage?

The financial reports for the fiscal year 2023 indicates that The net worth of Ratnagene Lifescience Private Limited has experienced an upsurge of 9.21%.

What are the total open charges for Ratnagene Lifescience Private Limited?

As per the financial statements for fiscal Year 2023, The total open charges for Ratnagene Lifescience Private Limited amount to ₹ 772500000.0.

When was the last Balance Sheet of Ratnagene Lifescience Private Limited filed with the ROC?

The most recent Balance Sheet for Ratnagene Lifescience Private Limited was filed with the ROC on 31 Mar 2023.

Ratnagene Lifescience Private Limited

Ratnagene Lifescience Profile

Key Indicators

Authorised Capital ₹ 9.00 Cr as on 18-01-2025
Paid Up Capital ₹ 6.86 Cr as on 18-01-2025
Company Age 3 Year, 4 Months
Last Filing with ROC 31 Mar 2023
Open Charges ₹ 77.25 Cr as on 18-01-2025
Revenue Growth % (FY 2023)
Net Worth 9.21% (FY 2023)
Total Assets 308.58% (FY 2023)

About Ratnagene Lifescience

Ratnagene Lifescience Private Limited (RLPL) is Amalgamated company established on 15 Sep 2021 with its office registered at Ahmedabad, Gujarat, India and has been running since 3 Year, 4 Months with a paid up capital of 6.86 Cr. According to MCA records, 5 Directors are linked to this company as of 18 Jan 2025.

Company Details

Location

Ahmedabad, Gujarat, India
Telephone
+91-XXXXXXXXXX
Email Address
Website

ratnagene.com
Social Media

Corporate Identity Details

CIN/LLPIN
U24231GJ2021PTC125613
Company No.
125613
Company Classification
Private Limited Indian Non-Government Company
Incorporation Date
15 Sep 2021
Date of AGM
30 Sep 2023
Date of Balance Sheet
31 Mar 2023
Listing Status
Unlisted
ROC Code
Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Ratnagene Lifescience?

Board Members (5)

Name	Designation	Appointment Date	Status
Vinay Khandelwal	Director	01-Sep-2022	Current
Rishabh Sanghvi	Director	15-Sep-2021	Current
Deval Shah	Director	05-Feb-2024	Current
Swapnil Shah	Director	15-Sep-2021	Current
Chetan Shah	Director	05-Feb-2024	Current

Financial Performance of Ratnagene Lifescience.

Ratnagene Lifescience Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 9.21%.

Graph illustrating revenue growth over time

Graph showing profit and loss trends over time

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

Revenue from Operations

Total Assets

308.58%

Profit or Loss

Net Worth

9.21%

EBITDA

What is the Ownership and Shareholding Structure of Ratnagene Lifescience?

In 2023, Ratnagene Lifescience had a promoter holding of 87.46% and a public holding of 12.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)

Open Charges

₹77.25 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 77.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
23 Jun 2023	Hdfc Bank Limited	₹40.00 Cr	Open
03 Apr 2023	Hdfc Bank Limited	₹37.25 Cr	Open

How Many Employees Work at Ratnagene Lifescience?

Ratnagene Lifescience has a workforce of 45 employees as of Jan 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ratnagene Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ratnagene Lifescience's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Ratnagene Lifescience Private Limited